
A rare blood disorder related to people missing a protein, called PAI-1, was identified in a small Amish community. Douglas Vaughan, MD, studies the community and found that those without the protein seem to live longer and healthier lives.

Through his research and practice as a preventive cardiologist at Northwestern, Donald Lloyd-Jones is working to improve and preserve the heart health of Americans, one patient at a time.

Marilyn Cornelis, PhD, PhD, studies the genetics of coffee consumption, caffeine metabolism and taste preferences and has some new findings to share about one of the most popular beverages in the world.

A common, safe and inexpensive drug for type 2 diabetes, metformin, decreases the risk of heart attacks and strokes triggered by particulate matter air pollution.

A. Vania Apkarian, PhD, explains his recent discoveries related to chronic pain and how placebos may be a very effective option for some.

Jeffrey Linder, MD, MPH, has developed effective ways to reduce the number of inappropriate prescriptions.

A new blood test developed at Northwestern has the potential to advance treatments of a variety of disorders and diseases.

More than 50 percent of women who are of childbearing age are overweight or obese, which may put them at risk for complications during pregnancy and child birth and affect their babies’ health, too.

Robert Kalb, MD, Director of the Les Turner ALS Center at Northwestern Medicine is optimistic that more breakthroughs in the basic biology of the disease are on the way and a cure is possible.

Brian Mustanski, PhD, is leading an effort to study, intervene and improve the health of the sexual and gender minority community.